NCT04387266已完成不适用
A Retrospective Real-world Study in Patients With Nasopharyngeal Carcinoma: to Evaluate the Efficacy and Feasibility of Modified Reduce-volume Target IMRT in the Treatment of Patients With Non-metastatic NPC
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 471
- 试验地点
- 1
- 主要终点
- Local failure-free survival (LFFS)
研究概览
简要总结
This is a retrospective real-world study to evaluate the efficacy and feasibility of modified reduce-volume target IMRT in the treatment of patients with non-metastatic NPC
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Pathologic diagnosis (pathologically confirmed by nasopharyngeal biopsy) was nasopharyngeal carcinoma;
- •Newly diagnosed, non-metastatic and treated with modified reduce-volume IMRT;
- •Patients with baseline MRI date of nasopharynx and neck, and completed the first course of treatment in our hospital;
- •Diagnosis time: November 1, 2014 to December 31 , 2017
排除标准
- •Disease progression during IMRT;
- •Previous malignancy or other concomitant malignant diseases;
- •The evaluation information of tumor efficacy can not be obtained;
- •Receive blind treatment in other clinical research.
结局指标
主要结局
Local failure-free survival (LFFS)
时间窗: 60 month
The duration of time to LFFS was calculated from the date of histological diagnosis until documented treatment local failure.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter StudyLeukemia, Lymphocytic, Acute, AdultNCT06649422Shandong University36
尚未招募
不适用
Real-world Study of Local Therapy Changes During 1L Lorlatinib in Unresectable ALK+ NSCLCLung Cancer, Non-Small CellNCT06690541Peking University Cancer Hospital & Institute100
已完成
不适用
A Real-world Study on Patients of Unresectable Giant Cell Tumor of BoneGiant Cell Tumor of BoneNCT05402865Shanghai JMT-Bio Inc.301
撤回
不适用
A Retrospective Study to Describe Real-World Treatment Patterns and Clinical Outcomes Among Patients With Myelodysplastic SyndromesMyelodysplastic Syndromes (MDS)NCT06581055Bristol-Myers Squibb86
进行中（未招募）
不适用
A Study Assessing Repatha® in Combination With Standard of Care (SOC) Compared With SOC on Major Cardiovascular Events in Chinese Participants With Atherosclerotic Cardiovascular DiseaseNCT06295679Amgen7,000